Literature DB >> 35300080

Conversion of a PROTAC Mutant Huntingtin Degrader into Small-Molecule Hydrophobic Tags Focusing on Drug-like Properties.

Keigo Hirai1, Hiroko Yamashita2, Shusuke Tomoshige1, Yugo Mishima1, Tatsuya Niwa3, Kenji Ohgane2, Mayumi Ishii4, Kayoko Kanamitsu4, Yui Ikemi5, Shinsaku Nakagawa5, Hideki Taguchi3, Shinichi Sato1,6, Yuichi Hashimoto2, Minoru Ishikawa1.   

Abstract

The onset of neurodegenerative disorders (NDs), such as Alzheimer's disease, is associated with the accumulation of aggregates of misfolded proteins. We previously showed that chemical knockdown of ND-related aggregation-prone proteins can be achieved by proteolysis targeting chimeras (PROTACs). However, hetero-bifunctional PROTACs generally show poor permeability into the central nervous system, where NDs are located. Here, we document the conversion of one of our PROTACs into hydrophobic tags (HyTs), another class of degraders bearing hydrophobic degrons. This conversion decreases the molecular weight and the number of hydrogen bond donors/acceptors. All the developed HyTs lowered the level of mutant huntingtin, an aggregation-prone protein, with potency comparable to that of the parent PROTAC. Through IAM chromatography analysis and in vivo brain penetration assay of the HyTs, we discovered a brain-permeable HyT. Our results and mechanistic analysis indicate that conversion of protein degraders into HyTs could be a useful approach to improve their drug-like properties.
© 2022 American Chemical Society.

Entities:  

Year:  2022        PMID: 35300080      PMCID: PMC8919385          DOI: 10.1021/acsmedchemlett.1c00500

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  28 in total

1.  Application of protein knockdown strategy targeting β-sheet structure to multiple disease-associated polyglutamine proteins.

Authors:  Hiroko Yamashita; Shusuke Tomoshige; Sayaka Nomura; Kenji Ohgane; Yuichi Hashimoto; Minoru Ishikawa
Journal:  Bioorg Med Chem       Date:  2019-10-31       Impact factor: 3.641

2.  Rapid screening of blood-brain barrier penetration of drugs using the immobilized artificial membrane phosphatidylcholine column chromatography.

Authors:  Chi Ho Yoon; Soo Jin Kim; Beom Soo Shin; Kang Choon Lee; Sun Dong Yoo
Journal:  J Biomol Screen       Date:  2005-11-28

3.  Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone.

Authors:  C Prodromou; S M Roe; R O'Brien; J E Ladbury; P W Piper; L H Pearl
Journal:  Cell       Date:  1997-07-11       Impact factor: 41.582

4.  Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1.

Authors:  J Zou; Y Guo; T Guettouche; D F Smith; R Voellmy
Journal:  Cell       Date:  1998-08-21       Impact factor: 41.582

Review 5.  Targeting protein aggregation for the treatment of degenerative diseases.

Authors:  Yvonne S Eisele; Cecilia Monteiro; Colleen Fearns; Sandra E Encalada; R Luke Wiseman; Evan T Powers; Jeffery W Kelly
Journal:  Nat Rev Drug Discov       Date:  2015-09-04       Impact factor: 84.694

Review 6.  Hybrid molecules with a dual mode of action: dream or reality?

Authors:  Bernard Meunier
Journal:  Acc Chem Res       Date:  2007-08-01       Impact factor: 22.384

Review 7.  Selective Degradation of Target Proteins by Chimeric Small-Molecular Drugs, PROTACs and SNIPERs.

Authors:  Minoru Ishikawa; Shusuke Tomoshige; Yosuke Demizu; Mikihiko Naito
Journal:  Pharmaceuticals (Basel)       Date:  2020-04-21

8.  Solution Conformations Shed Light on PROTAC Cell Permeability.

Authors:  Yoseph Atilaw; Vasanthanathan Poongavanam; Caroline Svensson Nilsson; Duy Nguyen; Anja Giese; Daniel Meibom; Mate Erdelyi; Jan Kihlberg
Journal:  ACS Med Chem Lett       Date:  2020-12-25       Impact factor: 4.345

Review 9.  Imaging Protein Misfolding in the Brain Using β-Sheet Ligands.

Authors:  Ryuichi Harada; Nobuyuki Okamura; Shozo Furumoto; Kazuhiko Yanai
Journal:  Front Neurosci       Date:  2018-08-21       Impact factor: 4.677

10.  Developing degraders: principles and perspectives on design and chemical space.

Authors:  Hannah J Maple; Nat Clayden; Anne Baron; Callum Stacey; Robert Felix
Journal:  Medchemcomm       Date:  2019-08-12       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.